TheCentre for Bioengineering and Biotechnologyand the University of ݮƵOffice of Research Ethicsare pleased to host an information session with.
Clinical Trials Ontario (CTO) representatives will detail
Professor Karim Karim will discuss his real-life challenges with the biotechnology company KA Imaging.Afocus on issues in the current pandemic climate.
Join us via Webex:
COVID-19 has shaken the world, challenging societies and altering life as we know it. But from this crisis, opportunities have emerged calling us to action as we prepare torebootfrom the COVID-19 lockdown.
COVID-19 has shaken the world, challenging societies and altering life as we know it. But from this crisis, opportunities have emerged calling us to action as we prepare torebootfrom the COVID-19 lockdown.
COVID-19 has shaken the world, challenging societies and altering life as we know it. But from this crisis, opportunities have emerged calling us to action as we prepare torebootfrom the COVID-19 lockdown.
The Centre for Bioengingeering and Biotechnology is proud to showcase student research with ourCBB Student Showcaseseries. Each student will be giving a 30 minute seminarthat will include time for questions.
The Centre for Bioengineering and Biotechnology is pleased to present the innovative work of Professor Alexander Wong.
COVID-19 has brought disease and mortality at levels not seen from a respiratory virus for over 100 years. Immune responses to this virus, which can infect several different tissues, are poorly understood, including the role of antibodies in resolving the infection. In March 2020, we reoriented our lab to develop Enzyme-Linked ImmunoSorbent Assays (ELISA) for human antibody isotypes IgM, IgG and IgA produced in response to the SARS-CoV-2 spike protein. To date we have analyzed samples from 114 patients, including both PCR positive and PCR negative individuals.
Brendan will discuss his research on the innovation processes of Grand River Hospital, Kids Ability, and Schlegel Villages as well as provide an introduction to the concept of open-innovation, specifically in healthcare.
He will also provide an overview of a Workplace Innovation Program that uses a similar innovation management model to CREATE. As part of that program, they use a needs “Needs Finding and Assessment” process to help teams identify the most valuable and viable opportunities for new products and services.
Rohan Shanbhag, VP of ML and AI Strategy, will be discussing how has developed a personalized health and wellness platform driven by a proprietary machine learning algorithm on-device that uses passively collected biometric data from wearables to predict the onset of illness before symptoms appear. Achu Health aims to assess the scientific rigour of its technology to ensure that the evaluation can be backed by Health Science professionals in providing meaningful value to the end user.